C-Path and Provention Bio Announce Data Sharing Collaboration to Develop Advanced Drug Development Tools in Type 1 Diabetes TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas
C-Path Appoints Two New Members to Board of Directors TUCSON, Ariz., April 30, 2020 — Tucson-based Critical Path Institute (C-Path) today announced the appointment of two new
C-Path ePRO Consortium and PRO Consortium Announce COVID-19 Risk Assessment and Mitigation Strategies Recommendations provided for sponsors and eCOA providers to facilitate the continued collection of PRO data in clinical trials. &n
June 5, 2020 Watch now: What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform Webinar Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera
C-Path Receives Letter of Support from EMA on Type 1 Diabetes Biomarker Initiative TUCSON, Ariz., April 28, 2020 — The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D
April 27, 2020 Critical Path for Parkinson’s Consortium 3DT Initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials A subset of CPP member organizations* have convened to collaborate precompetitively with the goal of optimizing the efficiency of
April 21, 2020 Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: the 2019 Expert Consensus From the Transplant Society Working Group
C-Path Awarded FDA Contract to Enhance the Assessment of Clinical Outcomes in Pediatric Asthma Treatment Trials Resulting novel drug development tools will support patient-focused drug development for children with asthma TUCSON
ePRO Consortium Announces COVID-19 Risk Assessment and Mitigation Strategies for Sponsors and eCOA Providers for Collection of PRO Data through Clinical Sites In collaboration with C-Path’s PRO Consortium, the ePRO Consortium has developed the presentation titled “Coronavirus D
May 7, 2021 VIEW NOW: COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w